RSSCategory: Pharmaceuticals

Longer dose interval between vaccinations produces stronger immune response

December 2, 2021

Delaying the second dose of mRNA COVID-19 vaccination brings about a stronger immune response, claim investigators of study conducted under the Canadian COVID-19 Immunity Task Force (CITF). The peer-reviewed study looked into how the pandemic has affected paramedics in North […]

Continue Reading

Current vaccines likely ineffective against new coronavirus variant

November 30, 2021

The CEO of drugmaker Moderna, Stéphane Bancel, has said the current crop of COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus; and that it could take months to begin shipping a vaccine that […]

Continue Reading

India sitting on 200 million doses of COVID-19 vaccines, SII CEO says

November 18, 2021

Nearly 200 million doses of COVID-19 vaccines are lying unused in Indian states as people refuse to get vaccinated. “The vaccine industry has worked tirelessly to provide enough stocks for the nation,” said the CEO of top vaccine maker the […]

Continue Reading

Pilot clinical drug trial for treatment of infantile spasms

November 9, 2021

The first patient in an AC-21-024 study, a pilot clinical trial of tricaprilin for the treatment of Infantile Spasms, has been enrolled by Cerecin, a clinical-stage biotechnology company developing ketogenic agents as potential neurotherapeutics. Tricaprilin is an investigational oral drug under development for several neurological conditions, […]

Continue Reading

SCG/Formycon collaborate on COVID-19 drug FYB207 for Asia-Pacific

October 21, 2021

Innovative biotechnology companies, Singapore-based SCG Cell Therapy Pte Ltd (SCG), and Germany-based Formycon AG (Formycon), have entered into a collaboration and license agreement for a preclinical stage ACE2 immunoglobulin fusion protein, FYB207. The drug has shown promising potential against major […]

Continue Reading

Singapore signs supply agreement for Merck’s experimental oral COVID-19 drug

October 6, 2021

Merck and Co., Inc. (Merck), also known as MSD outside the US and Canada, has just announced a supply and purchase agreement with Singapore that will provide the Republic with access to Merck’s experimental oral antiviral drug for COVID-19. The […]

Continue Reading

Experimental pill for home treatment of COVID-19 passes clinical trials

October 4, 2021

An investigational oral antiviral treatment for SARS-CoV-2 has been shown to significantly reduce a person’s risk of hospitalisation or death from COVID-19, according to clinical trials conducted by pharmaceutical giant Merck, referred to as MSD outside of the US and […]

Continue Reading

Scientists call for reduced use of paracetamol by pregnant woman, cites neurological and reproductive disruption in children

September 27, 2021

Paracetamol (acetaminophen or APAP) is a common painkiller – of its many uses, it is one of the few available drugs to relieve pains such as fever and aches during pregnancy. However, a newly published consensus statement is calling for […]

Continue Reading

Anti-aging drugs effectively slow spinal disc degeneration in mice

September 6, 2021

Senolytic drugs, part of a new class of anti-aging medication, has been found to prevent age-related deterioration of spinal discs in animal experiments. Senolytic drugs work by removing destructive senescent cells which accumulate in all living tissues with age, essentially […]

Continue Reading

New treatment for blindness caused by wet age-related macular degeneration

September 3, 2021

The Malaysian chapter of global medical company Novartis has introduced a powerful drug that can help slow the progression of wet age-related macular degeneration (wet AMD) in affected elderly adults. Wet AMD is a chronic and progressive eye disease that […]

Continue Reading